• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.40% Nasdaq Down 0.22%

    Lpath Inc. (LPTN)

    -NasdaqCM
    2.89 Down 0.05(1.70%) 3:18PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.94
    Open:2.93
    Bid:2.85 x 4500
    Ask:2.89 x 100
    1y Target Est:11.00
    Beta:-0.38
    Next Earnings Date:N/A
    Day's Range:2.89 - 2.97
    52wk Range:2.30 - 5.17
    Volume:7,415
    Avg Vol (3m):41,307
    Market Cap:55.71M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):24.25
    P/S (ttm):8.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.13
    Quarterly EPS Est (Dec-14) :-0.34
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback